Pharmaceutical compositions for nasal delivery

Details for Australian Patent Application No. 2004216458 (hide)

Owner Britannia Pharmaceuticals Limited

Inventors Merkus, Franciscus W. H.; Adams, Gerald; Lambert, Peter Alan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004216458

PCT Pub. Number WO2004/075824

Priority 0304636.4 28.02.03 GB

Filing date 1 March 2004

Wipo publication date 10 September 2004

Acceptance publication date 25 March 2010

International Classifications

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/075824 Priority application(s): WO2004/075824

25 March 2010 Application Accepted

  Published as AU-B-2004216458

22 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216472-Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients

2004216456-Dilation device